Total Payments
$10,995
2024 Payments
$1,818
Companies
52
Transactions
798
Medicare Patients
10,692
Medicare Billing
$544,020
Payment Breakdown by Category
Food & Beverage$10,820 (98.4%)
Education$175.45 (1.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,820 | 791 | 98.4% |
| Education | $175.45 | 7 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,626 | 135 | $0 (2024) |
| ABBVIE INC. | $1,024 | 83 | $0 (2024) |
| Lilly USA, LLC | $882.77 | 84 | $0 (2024) |
| PFIZER INC. | $818.26 | 74 | $0 (2024) |
| GlaxoSmithKline, LLC. | $795.96 | 55 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $747.65 | 60 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $494.33 | 25 | $0 (2024) |
| Astellas Pharma US Inc | $464.22 | 22 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $427.10 | 26 | $0 (2024) |
| Amgen Inc. | $319.81 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,818 | 111 | ABBVIE INC. ($241.15) |
| 2023 | $1,977 | 120 | AbbVie Inc. ($324.42) |
| 2022 | $1,338 | 84 | Novo Nordisk Inc ($282.95) |
| 2021 | $1,459 | 106 | Novo Nordisk Inc ($265.77) |
| 2020 | $294.67 | 21 | Novo Nordisk Inc ($62.61) |
| 2019 | $1,451 | 116 | Novo Nordisk Inc ($252.17) |
| 2018 | $1,413 | 131 | Novo Nordisk Inc ($207.83) |
| 2017 | $1,244 | 109 | Janssen Pharmaceuticals, Inc ($177.47) |
All Payment Transactions
798 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: VACCINES | ||||||
| 12/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Inflammation | ||||||
| 12/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Gastroenterology | ||||||
| 11/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.14 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $1.38 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Obesity | ||||||
| 10/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: PSYCHIATRY | ||||||
| 10/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Cardio-renal | ||||||
| 09/30/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Genetic Disease | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | ABBVIE INC. | SYNTHROID (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.49 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.74 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 2,609 | 4,617 | $291,293 | $161,385 |
| 2022 | 39 | 2,450 | 3,394 | $255,829 | $108,835 |
| 2021 | 39 | 2,745 | 3,988 | $370,597 | $148,485 |
| 2020 | 41 | 2,888 | 4,220 | $338,082 | $125,314 |
Total Patients
10,692
Total Services
16,219
Medicare Billing
$544,020
Procedure Codes
155
All Medicare Procedures & Services
155 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 290 | 615 | $121,855 | $46,418 | 38.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 280 | 280 | $37,520 | $33,904 | 90.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 75 | 75 | $22,840 | $21,207 | 92.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 12 | 900 | $21,120 | $15,473 | 73.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 87 | 89 | $9,981 | $6,395 | 64.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 84 | 103 | $14,338 | $5,624 | 39.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 288 | 550 | $6,050 | $4,605 | 76.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 235 | 258 | $7,740 | $3,363 | 43.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 247 | 273 | $5,187 | $2,817 | 54.3% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 31 | 44 | $3,824 | $2,676 | 70.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 88 | 90 | $2,696 | $2,558 | 94.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 99 | 132 | $4,092 | $2,173 | 53.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 79 | 79 | $2,212 | $2,168 | 98.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 14 | 14 | $4,380 | $2,132 | 48.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 92 | 188 | $3,384 | $1,782 | 52.6% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 47 | 47 | $1,598 | $889.24 | 55.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 41 | 95 | $4,560 | $824.49 | 18.1% |
| 85610 | Blood test, clotting time | Office | 2023 | 13 | 173 | $1,384 | $726.60 | 52.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 12 | 13 | $1,722 | $688.10 | 40.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 45 | 46 | $1,288 | $679.88 | 52.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 80 | 88 | $1,320 | $663.19 | 50.2% |
| 82306 | Vitamin d-3 level | Office | 2023 | 22 | 22 | $1,188 | $638.22 | 53.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 14 | 14 | $1,540 | $505.70 | 32.8% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 33 | 50 | $900.00 | $414.50 | 46.1% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 11 | 15 | $705.00 | $379.35 | 53.8% |
About Dr. Jonathan Dixon, D.O
Dr. Jonathan Dixon, D.O is a Internal Medicine healthcare provider based in Bristol, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962430496.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Dixon, D.O has received a total of $10,995 in payments from pharmaceutical and medical device companies, with $1,818 received in 2024. These payments were reported across 798 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($10,820).
As a Medicare-enrolled provider, Dixon has provided services to 10,692 Medicare beneficiaries, totaling 16,219 services with total Medicare billing of $544,020. Data is available for 4 years (2020–2023), covering 155 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Bristol, TN
- Active Since 06/30/2006
- Last Updated 02/14/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1962430496
Products in Payments
- Ozempic (Drug) $652.97
- TRELEGY ELLIPTA (Drug) $536.02
- XARELTO (Drug) $475.65
- XIFAXAN (Drug) $391.45
- VRAYLAR (Drug) $349.50
- REXULTI (Drug) $300.92
- Kerendia (Drug) $296.81
- TRULICITY (Drug) $295.31
- NURTEC ODT (Drug) $271.98
- FARXIGA (Drug) $265.74
- Rybelsus (Drug) $249.23
- UBRELVY (Drug) $245.01
- MOUNJARO (Drug) $240.00
- MYRBETRIQ (Drug) $238.01
- ELIQUIS (Drug) $233.79
- CHANTIX (Drug) $228.21
- JARDIANCE (Drug) $193.33
- Victoza (Drug) $182.71
- Vascepa (Drug) $181.49
- Wegovy (Drug) $149.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bristol
Dr. Bernard Grunstra, Md, MD
Internal Medicine — Payments: $36,895
Internal Medicine $36,895
Charles Villoch, Md, MD
Internal Medicine — Payments: $25,124
Internal Medicine $25,124
Dr. Joseph Foley, M.d, M.D
Internal Medicine — Payments: $21,160
Internal Medicine $21,160
Dr. Nathan Gargus, M.d, M.D
Internal Medicine — Payments: $17,677
Internal Medicine $17,677
Rick Whiles, Md, MD
Internal Medicine — Payments: $17,415
Internal Medicine $17,415
Dr. Donald Quinn, Md, MD
Internal Medicine — Payments: $17,216
Internal Medicine $17,216